Vero Biotech's Series D Round

Vero Biotech raised a round of funding on October 18, 2013. Investors include SFW Capital Partners.

Vero Biotech, fka GeNO, is a privately-held biopharmaceutical company focused on the design, development and commercialization of next-generation products to address unmet medical needs of patients wi…

Articles about Vero Biotech's Series D Round: